Neurotech International Ltd (NTI)

Currency in AUD
0.014
0.000(0.00%)
Closed·
NTI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0140.014
52 wk Range
0.0100.029
Key Statistics
Bid/Ask
0.014 / 0.015
Prev. Close
0.014
Open
0.014
Day's Range
0.014-0.014
52 wk Range
0.01-0.029
Volume
7.62M
Average Volume (3m)
3.12M
1-Year Change
-26.3158%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NTI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Earnings

Latest Release
Aug 26, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-7.1K / --
EPS Revisions
Last 90 days

NTI Income Statement

Compare NTI to Peers and Sector

Metrics to compare
NTI
Peers
Sector
Relationship
P/E Ratio
−3.5x−7.0x−0.3x
PEG Ratio
−0.08−0.210.00
Price/Book
37.0x5.4x2.6x
Price / LTM Sales
4.8x2.6x3.0x
Upside (Analyst Target)
-109.0%58.5%
Fair Value Upside
Unlock9.0%7.1%Unlock

Neurotech International Limited, a clinical-stage biopharmaceutical development company, focuses on development of solutions for paediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy in Australia. The company develops NTI164 to treat autism spectrum disorder, paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, paediatric acute-onset neuropsychiatric syndrome, and Rett syndrome. It also engages in executing medical research projects; and developing technological devices. The company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its proprietary cannabis strains. The company has a collaboration with The University of Sydney. Neurotech International Limited was incorporated in 2016 and is based in Melbourne, Australia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
30.51M1.89%427.09K
Other Institutional Investors
386.97M23.94%5.42M
Public Companies & Retail Investors
1.20B74.17%16.78M
Total
1.62B100.00%22.62M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dutch Inc (2010) Pty Ltd5.84%94,341,2331,321
Merchant Funds Management Pty Ltd4.42%71,428,5711,000

FAQ

What Is the Neurotech Intl (NTI) Stock Price Today?

The Neurotech Intl stock price today is 0.014 AUD.

What Stock Exchange Does Neurotech Intl Trade On?

Neurotech Intl is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Neurotech Intl?

The stock symbol for Neurotech Intl is "NTI."

What Is the Neurotech Intl Market Cap?

As of today, Neurotech Intl market cap is 22.620M AUD.

What Is Neurotech Intl's Earnings Per Share (TTM)?

The Neurotech Intl EPS (TTM) is -0.006.

From a Technical Analysis Perspective, Is NTI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Neurotech Intl Stock Split?

Neurotech Intl has split 1 times.

What is the current trading status of Neurotech Intl (NTI)?

As of Oct 06, 2026, Neurotech Intl (NTI) is trading at a price of 0.014 AUD, with a previous close of 0.014 AUD. The stock has fluctuated within a day range of 0.014 AUD to 0.014 AUD, while its 52-week range spans from 0.010 AUD to 0.029 AUD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.